Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  •  Canada
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Science
      < Back
    • Science
    • Areas of Focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • People
    • Governance
    • Charitable Contributions
  • Patients

Post navigation

Next

Cabometyx® (cabozantinib)

Cabometyx® (cabozantinib)

- 20 August 2024 - 0 mins read

Post navigation

Next
Related Documents
  • Click here to view Product Monograph   Download  (773 KB)

Related Products

IQIRVO® (elafibranor)
28 April 2025 0 mins read

IQIRVO® (elafibranor)
Sohonos® (palovarotene)
20 August 2024 0 mins read

Sohonos® (palovarotene)
Somatuline Autogel<sup>®</sup> (lanreotide injection)
20 August 2024 0 mins read

Somatuline Autogel® (lanreotide injection)
Onivyde® (irinotecan liposome injection)
20 August 2024 0 mins read

Onivyde® (irinotecan liposome injection)
Increlex<sup>®</sup> (mecasermin)
20 August 2024 0 mins read

Increlex® (mecasermin)
Dysport<sup>®</sup> (abobotulinumtoxinA)
20 August 2024 0 mins read

Dysport® (abobotulinumtoxinA)

IPN price

€163.70

 €2.90 (1.80%)

  • Investors
  • Partnering
  • Careers
  • Who We Are
  • Sustainability
  • Contact us
Ipsen logo
Linkedin Instagram Facebook Youtube
  • Terms of Use
  • Cookie Policy
  • Privacy Policy
  • Accessibility

© Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen Canada website. To continue, please click Continue.

Continue